Medicated Skin Care in Serbia

Date: July 25, 2012
Pages: 28
Price:
US$ 900.00
Publisher: Euromonitor International Ltd
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: MBE686A4506EN
Leaflet:

Download PDF Leaflet

Medicated Skin Care in Serbia
Increasing health awareness was the key factor which drove sales of medicated skin care products in 2011. At the same time, the variety of available products saw a constant increase, as well as their distribution, which brought medicated skin care products much closer to Serbian consumers than ever before. The current value increase of 14% was mostly a consequence of the high inflation rate in 2011, as the constant value increase was 4%, which is an indicator of growth in volume sales of these...

Euromonitor International's Medicated Skin Care in Serbia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Medicated Skin Care market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of Medicated Skin Care by Category: Value 2006-2011
  Table 2 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  Table 3 Medicated Skin Care Company Shares by Value 2007-2011
  Table 4 Medicated Skin Care Brand Shares 2008-2011
  Table 5 Hair Loss Treatments Brand Shares 2008-2011
  Table 6 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  Table 7 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016
Galenika Ad in Consumer Health (serbia)
Strategic Direction
Key Facts
  Summary 1 Galenika ad: Key Facts
  Summary 2 Galenika ad: Operational Indicators
Company Background
Production
  Summary 3 Galenika ad: Production Statistics 2011
Competitive Positioning
  Summary 4 Galenika ad: Competitive Position 2011
Hemofarm Ad in Consumer Health (serbia)
Strategic Direction
Key Facts
  Summary 5 Hemofarm ad: Key Facts
  Summary 6 Hemofarm ad: Operational Indicators
Company Background
Production
  Summary 7 Hemofarm ad: Production Statistics 2011
Competitive Positioning
  Summary 8 Hemofarm ad: Competitive Position 2011
Zdravlje-leskovac Pharmaceutical & Chemical Industry in Consumer Health (serbia)
Strategic Direction
Key Facts
  Summary 9 Zdravlje-Leskovac Pharmaceutical & Chemical Industry: Key Facts
  Summary 10 Zdravlje-Leskovac Pharmaceutical & Chemical Industry: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 11 Zdravlje-Leskovac Pharmaceutical & Chemical Industry: Competitive Position 2011
Executive Summary
Increasing Health Awareness Is A Key Generator of Growth in the Review Period
2011 Is Marked by the Rapid Expansion of Paediatric Products
the Arrival of Private Label in 2011
Increase in the Number of Chemists/pharmacists
Slow and Stable Growth Expected
Key Trends and Developments
International Players Slowly Take Share From Domestic Players
Being Healthy Becomes Trendy
A Shift From Informal To Formal Trade in Dietary Supplements in Serbia
Ageing of the Serbian Population
Adapting Serbian Legislation To EU Standards
Market Indicators
  Table 8 Life Expectancy at Birth 2006-2011
Market Data
  Table 9 Sales of Consumer Health by Category: Value 2006-2011
  Table 10 Sales of Consumer Health by Category: % Value Growth 2006-2011
  Table 11 Consumer Health Company Shares 2007-2011
  Table 12 Consumer Health Brand Shares 2008-2011
  Table 13 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  Table 14 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  Table 15 Forecast Sales of Consumer Health by Category: Value 2011-2016
  Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
  Summary 12 OTC Healthcare Switches 2009-2011
Definitions
Sources
  Summary 13 Research Sources
Medicated Skin Care in Colombia US$ 900.00 May, 2012 · 35 pages
Medicated Skin Care in New Zealand US$ 900.00 Mar, 2012 · 36 pages
Medicated Skin Care in Venezuela US$ 900.00 Apr, 2012 · 30 pages
Medicated Skin Care in Brazil US$ 900.00 May, 2012 · 46 pages
Medicated Skin Care in Canada US$ 900.00 Feb, 2012 · 34 pages

Ask Your Question

Medicated Skin Care in Serbia
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: